Telomerase-specific fluorescent navigation system for lung cancer surgery
Telomerase-specific fluorescent navigation system for lung cancer surgery
批准号:
17390381
负责人:
FUJIWARA Toshiyoshi
金额:
$9.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
目前可用的体内肿瘤检测方法,如x射线、计算机断层扫描和超声检查是无创的,并且研究得很好;然而,这些图像并不是针对肿瘤的。活体肿瘤细胞的直接光学成像可以清楚地将其与周围的正常组织区分开来,这在临床上可能是有用的。在这里,我们描述了一种可视化肿瘤的新方法,其荧光可以通过表达绿色荧光蛋白(GFP) (OBP-401)的端粒酶特异性复制能力腺病毒来检测。OBP-401包含复制盒,其中人类端粒酶逆转录酶(hTERT)启动子驱动El基因的表达,以及用于监测病毒复制的GFP基因。hTERT是端粒酶的催化亚基,端粒酶在癌细胞中高度活跃,但在大多数正常体细胞中处于静止状态。当OBP-401感染人肺癌细胞系H1299时,病毒在肿瘤细胞中复制,并表现出强烈的绿色信号。相比之下,OBP-401感染在正常细胞如成纤维细胞中未显示任何信号。我们还发现,瘤内注射OBP-401后,已建立的皮下肿瘤可以可视化。移植到BALB/c nu/nu小鼠体内的H1299人肺肿瘤瘤内注射1 × 10^8斑块形成单位(PFU)的OBP-401。在治疗24小时内,通过3CCD相机在这些肿瘤中可以看到表达的GFP的荧光。此外,胸廓内给药OBP-401可以显示胸廓内植入小鼠弥散性A549肿瘤结节。结果表明,瘤内或胸内注射OBP-401可能是一种有效的诊断方法,为今后的临床应用提供了基础。
英文摘要
Currently available methods for detection of tumors in vivo such as X-ray, computed tomography, and ultrasonography are noninvasive and well studied; the images, however, are not specific for tumors. Direct optical imaging of tumor cells in vivo that can clearly distinguish them from surrounding normal tissues may be clinically useful. Here, we describe a new approach to visualizing tumors whose fluorescence can be detected using telomerase-specific replication-competent adenovirus expressing green fluorescent protein (GFP) (OBP-401). OBP-401 contains the replication cassette, in which the human telomerase reverse transcriptase (hTERT) promoter drives expression of El genes, and the GFP gene for monitoring viral replication. The hTERT is the catalytic subunit of telomerase, which is highly active in cancer cells, but is quiescent in most normal somatic cells. When the human lung cancer cell line H1299 was infected with OBP-401, the virus replicated in tumor cells and showed strong green signals. In contrast, infection of OBP-401 did not show any signals in normal cells such as fibroblasts. We also found that established subcutaneous tumors could be visualized following intratumoral injection of OBP-401. H1299 human lung tumors transplanted into BALB/c nu/nu mice were intratumorally injected with 1 x 10^8 plaque forming units (PFU) of OBP-401. Within 24 hours of treatment, the fluorescence of the expressed GFP became visible by 3CCD camera in these tumors. Moreover, intrathoracic administration of OBP-401 could visualize disseminated A549 tumor nodules in mice following intrathoracic implantation. Our results indicate that intratumoral or intrathoracic injection of OBP-401 might be a useful diagnostic method that provides a foundation for future clinical application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/ijc.21846
发表时间:
2006-07-15
期刊:
INTERNATIONAL JOURNAL OF CANCER
影响因子:
6.4
作者:
[Fujiwara, Toshiya, Kagawa, Shunsuke, Fujiwara, Toshiyoshi]
通讯作者:
Fujiwara, Toshiyoshi
悪性腫瘍に対するウイルス製剤Telomelysinの臨床開発.
用于恶性肿瘤的病毒药物 Telomelysin 的临床开发。
DOI:
--
发表时间:
2006
期刊:
Biotherapy 20
影响因子:
--
作者:
[Watanabe, T., 藤原俊義]
通讯作者:
藤原俊義
DOI:
10.1038/nm1404
发表时间:
2006-10-01
期刊:
NATURE MEDICINE
影响因子:
82.9
作者:
[Kishimoto, Hiroyuki, Kojima, Toru, Fujiwara, Toshiyoshi]
通讯作者:
Fujiwara, Toshiyoshi
DOI:
10.1038/sj.onc.1208460
发表时间:
2005-04-28
期刊:
ONCOGENE
影响因子:
8
作者:
[Taki, M, Kagawa, S, Fujiwara, T]
通讯作者:
Fujiwara, T
Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells
组蛋白脱乙酰酶抑制剂 FR901228 增强端粒酶特异性复制选择性腺病毒药物 OBP-301 在人肺癌细胞中的抗肿瘤作用
DOI:
--
发表时间:
2006
期刊:
Experimental Cell Research 312
影响因子:
--
作者:
[Watanabe, T.]
通讯作者:
T.
Development of the Dual fluorescent cytology with tumor-specific viruses for gastrointestinal cancer precision medicine
-
批准号:16H05416
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.32万
-
财政年份:2016
-
负责人:FUJIWARA Toshiyoshi
-
依托单位:
Fluorescent virus-guided capturing of epithelial-mesenchymal transition (EMT)-induced circulating tumor cells (CTCs) for genetic analysis
-
批准号:25670580
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:FUJIWARA Toshiyoshi
-
依托单位:
"Cell-in-cell" activity-based tumor-specific delivery of biologics
-
批准号:25293283
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2013
-
负责人:FUJIWARA Toshiyoshi
-
依托单位:
Molecular therapy for gastric cancer using HER2-extracellular domain-expressing adenovirus
-
批准号:22390256
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.4万
-
财政年份:2010
-
负责人:FUJIWARA Toshiyoshi
-
依托单位:
Telomerase-specific virotherapy for malignant mesothelioma
-
批准号:19390365
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.98万
-
财政年份:2007
-
负责人:FUJIWARA Toshiyoshi
-
依托单位:
Molecular Fluorescent Imaging of Metastatic Tumors with Conditionally Replication-Selective Adenovirus and GFP Gene
-
批准号:15591475
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:FUJIWARA Toshiyoshi
-
依托单位:
Molecular Analysis of Resistance to p53 Gene Therapy in Human Lung Cancer
-
批准号:13671390
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2001
-
负责人:FUJIWARA Toshiyoshi
-
依托单位:
Development of Gene Therapy for Lung Cancer using a Novel Antiangiogenic Factor BAI1
-
批准号:11671325
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:FUJIWARA Toshiyoshi
-
依托单位:
海外基金